InVivoMAb anti-human CD28

Huang X, Williams JZ, Chang R, et al. DNA scaffolds enable efficient and tunable functionalization of biomaterials for immune cell modulation. Nat Nanotechnol. 2021,16(2):214-223. doi: 10.1038/s41565-020-00813-z

Koh J, Kim Y, Lee KY, et al. MDSC subtypes and CD39 expression on CD8(+) T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC. Eur J Immunol. 2020,50(11):1810-1819. doi: 10.1002/eji.202048534

Hill EV, Ng TH, Burton BR, et al. Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter. Eur J Immunol. 2015,45(4):1103-15. doi: 10.1002/eji.201444661

Bushkin Y, Radford F, Pine R, et al. Profiling T cell activation using single-molecule fluorescence in situ hybridization and flow cytometry. J Immunol. 2015,194(2):836-41. doi: 10.4049/jimmunol.1401515

Kovacs B, Parry RV, Ma Z, et al. Ligation of CD28 by its natural ligand CD86 in the absence of TCR stimulation induces lipid raft polarization in human CD4 T cells. J Immunol. 2005,175(12):7848-54.